Intended for healthcare professionals

Letters

Ecstasy and neurodegeneration

BMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7054.423 (Published 17 August 1996) Cite this as: BMJ 1996;313:423

Advice is that “less is more”

  1. John Merrill
  1. Consultant in drug dependence Drugs North West, Manchester M25 7BL

    EDITOR,—A Richard Green and Guy M Goodwin rightly point out that the risk of long term consequences of neurodegeneration associated with the use of ecstasy (3,4-methylenedioxymethamphetamine) may be greater than the risk of death from acute toxicity.1 Having reviewed the compelling evidence linking ecstasy with neurotoxicity in animals, they omit what is perhaps the strongest indication of neurotoxicity in humans.

    A universal …

    View Full Text

    Log in

    Log in through your institution

    Subscribe

    * For online subscription